Nigeria’s family planning needs are growing faster than govt funding

Nigeria’s demand for modern family planning services is rising rapidly, but public funding for contraceptives and related services is failing to keep pace, exposing growing gaps in access for millions of women, according to the Family Planning Market Report 2025.

The report identifies Nigeria as one of the largest drivers of family planning demand in Africa, reflecting the country’s fast-growing population, high fertility rate, and low use of modern contraception. Nigeria has one of the highest numbers of women with unmet need for family planning globally, yet funding and supply systems remain fragile and heavily dependent on external support.

Nigeria is one of only six countries among the 85 surveyed that has “consistently featured in the top 10 largest markets by value between 2020 and 2024.”

Across sub-Saharan Africa, the report finds that demand for contraceptives is expanding faster than government and donor financing. Nigeria stands out because of its scale. With Africa now the fastest-growing family planning market worldwide, Nigeria alone accounts for a substantial share of projected growth in demand for short-acting and long-acting contraceptive methods.

Despite this, the report notes that public funding for family planning commodities in Nigeria remains inconsistent and vulnerable to budget pressures.

Government allocations often fall short of forecast needs, while currency instability and rising import costs have increased the price of procuring contraceptives. As a result, stock-outs persist in public health facilities, forcing many women to turn to private providers or go without care.

High Demand for Injectables and Implants

The Family Planning Market Report 2025, published by the Clinton Health Access
Initiative and the Reproductive Health Supplies Coalition, shows that donor funding still plays an outsized role in Nigeria’s contraceptive market, particularly for implants, injectables, and intrauterine devices.

However, donor support across several countries has plateaued in real terms, even as population growth and demand continue to rise. This mismatch, the report warns, threatens the sustainability of access in high-burden countries like Nigeria.

Method mix data in the report indicate that injectable contraceptives and implants continue to dominate demand in Nigeria and neighbouring countries, driven by preference for longer-acting options. Yet these methods are also among the most affected by supply-chain disruptions, long procurement cycles, and funding shortfalls.

The report further highlights that Nigeria’s unmet need is concentrated among young women, rural populations, and low-income households – groups least able to absorb out-of-pocket costs when public supplies are unavailable.

While Nigeria’s private sector has expanded its role through pharmacies, clinics, and social marketing organisations, affordability remains a barrier without subsidies or insurance coverage.

Regionally, Africa’s family planning market is projected to grow faster than any other region through 2030, but the report cautions that growth driven solely by private expenditure risks widening inequality. Without sustained increases in domestic public financing, Nigeria could see rising overall contraceptive use alongside persistent exclusion of the poorest women.

The report frames Nigeria’s situation as a policy inflection point. Meeting rising family planning needs will require not only increased donor support but stronger domestic financing, better forecasting, and more resilient procurement systems.

Without those measures, demand will continue to outstrip supply – with implications for maternal health, household welfare, and long-term economic growth.